Stereotactic Intracerebral Injection of Allogenic IPSC-DAPs in Patients With Parkinson's Disease
Clinical trial NCT07212088 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07212088
- Sponsor
- iCamuno Biotherapeutics Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-28
- Primary completion
- 2027-12-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.